Cancer treatment facilities market seen reaching $70.52 billion by 2030

The Business Research Company projects the global cancer treatment facilities market will grow from $48.27 billion in 2025 to $52.19 billion in 2026, then reach $70.52 billion by 2030. The forecast points to rising cancer incidence, expanding oncology capacity and wider use of advanced treatments as the main drivers.

Why it matters: - The forecast signals sustained demand for specialized cancer care as global cancer rates rise. - Growth in treatment facilities can shape access to chemotherapy, radiation therapy, immunotherapy and other oncology services. - The report also points to Asia-Pacific as the fastest-growing region, which may influence where new capacity and investment concentrate.

What happened: - The Business Research Company released a market forecast report on cancer treatment facilities on November 6, 2026. - The report values the market at $48.27 billion in 2025 and projects $52.19 billion in 2026. - The forecast says the market will reach $70.52 billion by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published a free sample of the market report. - The company also posted the full market report.

The details: - The report says the market grew on the back of higher global cancer prevalence, expanded oncology departments in hospitals, wider availability of chemotherapy and radiation technologies, stronger awareness of early detection and more trained oncology professionals. - The forecast period through 2030 assumes more investment in cancer research infrastructure, broader use of immunotherapy and targeted therapies, progress in personalized medicine and deeper use of digital health tools in oncology care. - The report highlights precision oncology, advanced diagnostics, multidisciplinary care models, specialized cancer centers and patient-centered care as key trends. - Cancer treatment facilities are described as specialized healthcare institutions that provide diagnosis, management and treatment for cancer patients using advanced technologies, trained staff and evidence-based protocols. - The American Association for Cancer Research estimated 20 million new cancer diagnoses worldwide in September 2025, along with more than 10.3 million cancer-related deaths. - The AACR also estimated that about 53.5 million people were living at least five years after a cancer diagnosis. - Asia-Pacific held the largest market share in 2025 and is expected to be the fastest-growing region through the forecast period. - The report links Asia-Pacific growth to expanding healthcare infrastructure, rising cancer rates and increased oncology spending.

Between the lines: - The forecast reflects a broader shift from basic cancer care toward more specialized, technology-enabled treatment networks. - The emphasis on personalized medicine and digital tools suggests competition will likely center on treatment capability, coordination and patient experience, not just bed count or square footage. - The regional outlook suggests emerging health systems in Asia-Pacific may capture a disproportionate share of new oncology investment.

What's next: - The market is expected to keep expanding as cancer incidence rises and health systems add oncology capacity. - Facilities that adopt immunotherapy, targeted treatment and precision diagnostics may be better positioned for demand over the next several years. - The report says future growth will also depend on integrated cancer services and more patient-centered care models.

The bottom line: - Cancer treatment facilities are moving from a niche healthcare segment to a larger, faster-growing global market tied to rising cancer burden and more advanced care delivery.